Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
Tags Novo Nordisk A/S Eli Lilly and Co Breaking News: Investing
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
Tags Bristol/Myers Squibb Co Novo Nordisk A/S Biotechnology
From CNBC.com News
Here are the big health sector themes to watch next year
Tags Eli Lilly and Co Dexcom Inc Humana Inc
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Biotech and Pharmaceuticals Health & Science Eli Lilly and Co
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Nike Inc Novo Nordisk A/S Markets
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Business News Weight management Health care industry
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
Tags Health & Science Science Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags Business News Health care industry Novo Nordisk A/S
From CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
Tags Investing Breaking News: Politics Markets
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Eli Lilly and Co Stock Picks Investment Strategy
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Health care industry Novo Nordisk A/S Biotechnology
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Eli Lilly and Co Biotech and Pharmaceuticals Science
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Business News Pharmaceuticals Health care industry
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Eli Lilly and Co Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags Stock Picks Eli Lilly and Co Investment Strategy
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Business News Pfizer Inc Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Markets Investing TJX Companies Inc
From CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
Tags Business Social issues Business News
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
Tags Home Depot Inc Macy's Inc U/S/ Markets
From CNBC.com News
Cramer's Lightning Round: Buy AutoZone
Tags S&P 500 Investing stocks
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
Tags Biotech and Pharmaceuticals Health & Science Science
From CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Tags Pharmaceuticals Biotechnology Novo Nordisk A/S
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Breaking news Companies Business
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
Tags Novo Nordisk A/S Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Weight management Business News Pharmaceuticals
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags Seagen Inc US: News Business
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Health & Science Mobile Dexcom Inc
From CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
Tags Banks Advanced Micro Devices Inc Daily Open
From CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
Tags Hess Corp Inflation Chevron Corp
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
Tags Investment strategy Investing Health & Science
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.